Wealthstreet Investment Advisors LLC boosted its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 8.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 43,507 shares of the financial services provider’s stock after buying an additional 3,236 shares during the quarter. Wealthstreet Investment Advisors LLC’s holdings in iShares Nasdaq Biotechnology ETF were worth $4,746,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in IBB. Stone House Investment Management LLC purchased a new stake in iShares Nasdaq Biotechnology ETF in the 1st quarter valued at $27,000. Trustcore Financial Services LLC purchased a new stake in iShares Nasdaq Biotechnology ETF in the 1st quarter valued at $34,000. Meridian Wealth Management LLC purchased a new stake in iShares Nasdaq Biotechnology ETF in the 1st quarter valued at $36,000. Aspire Private Capital LLC purchased a new stake in iShares Nasdaq Biotechnology ETF in the 4th quarter valued at $40,000. Finally, Destination Wealth Management purchased a new stake in iShares Nasdaq Biotechnology ETF in the 1st quarter valued at $42,000. 72.66% of the stock is owned by institutional investors and hedge funds.

NASDAQ IBB traded up $0.51 on Tuesday, reaching $105.92. The company had a trading volume of 163,928 shares, compared to its average volume of 2,282,056. The business has a fifty day moving average price of $106.64. iShares Nasdaq Biotechnology ETF has a 52-week low of $89.01 and a 52-week high of $122.97.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Read More: What is a Tariff?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.